Active surveillance for prostate cancer is used to avoid treatment side effects in men with a very low risk of prostate cancer progression.
Because prostate cancer grows very slowly, men who are diagnosed when the cancer is very small may never have signs and symptoms of the disease. Many may live out their normal life spans before the cancer ever grows large enough to require treatment.
Active surveillance for prostate cancer may be appropriate for you if:
- Your cancer is small. If your cancer is found early, while it's still small and limited to one area of your prostate, active surveillance may be a reasonable choice.
- Your Gleason score is low. Active surveillance may be best suited for men with a low Gleason score (usually 6 or lower), which indicates a less aggressive, slower growing (indolent) form of cancer.
- You have other serious health problems. If you have other advanced health problems, such as severe heart disease, that limit your life expectancy and that could potentially be made worse by treatment of prostate cancer, you may opt for active surveillance.
Nov. 03, 2016
- Wein AJ, et al. Active surveillance of prostate cancer. In: Campbell-Walsh Urology. 11th ed. Philadelphia, Pa.: Elsevier; 2016. http://www.clinicalkey.com. Accessed Sept. 21, 2016.
- Prostate cancer. Fort Washington, Pa.: National Comprehensive Cancer Network. http://www.nccn.org/professionals/physician_gls/f_guidelines.asp. Accessed July 13, 2016.
Active surveillance for prostate cancer